Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 75
Publisher
MDPI AG
Online
2017-12-29
DOI
10.3390/ijms19010075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2
- (2017) Misa Iwatani-Yoshihara et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
- (2017) Qiuran Xu et al. Molecular Cancer
- A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
- (2017) Jin-Zhou Huang et al. MOLECULAR CELL
- Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS
- (2017) Sarah J. Ross et al. Science Translational Medicine
- A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay
- (2017) Zhiyuan Hu et al. Nature Communications
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
- (2017) Yukiya Sako et al. Scientific Reports
- Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
- (2017) Brenton R Paolella et al. eLife
- Global identification of hnRNP A1 binding sites for SSO-based splicing modulation
- (2016) Gitte H. Bruun et al. BMC BIOLOGY
- Role of p53 isoforms and aggregations in cancer
- (2016) SeJin Kim et al. MEDICINE
- Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1
- (2016) Dianne Pham et al. NATURAL PRODUCT REPORTS
- Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift
- (2016) Felipe Andrés Cordero Luz et al. ONCOLOGY
- Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in theATMGene
- (2016) Jana Kralovicova et al. Nucleic Acid Therapeutics
- Modulating splicing with small molecular inhibitors of the spliceosome
- (2016) Kerstin A. Effenberger et al. Wiley Interdisciplinary Reviews-RNA
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells
- (2015) So Jung Park et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Transposable Elements in Cancer and Other Human Diseases
- (2015) Benoit Chenais CURRENT CANCER DRUG TARGETS
- An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
- (2015) Graham McClorey et al. CURRENT OPINION IN PHARMACOLOGY
- Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
- (2015) Wies van Roosmalen et al. JOURNAL OF CLINICAL INVESTIGATION
- Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth
- (2015) Michael Dewaele et al. JOURNAL OF CLINICAL INVESTIGATION
- SRSF1-Regulated Alternative Splicing in Breast Cancer
- (2015) Olga Anczuków et al. MOLECULAR CELL
- hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers
- (2015) Yang Xuan et al. Molecular Oncology
- The spliceosome is a therapeutic vulnerability in MYC-driven cancer
- (2015) Tiffany Y.-T. Hsu et al. NATURE
- Intron retention is a widespread mechanism of tumor-suppressor inactivation
- (2015) Hyunchul Jung et al. NATURE GENETICS
- Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines
- (2015) ZHAOHUI LI et al. ONCOLOGY REPORTS
- CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer
- (2015) TIING JEN LOH et al. ONCOLOGY REPORTS
- Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
- (2015) Shinsuke Araki et al. PLoS One
- Disease-associated mutation inSRSF2misregulates splicing by altering RNA-binding affinities
- (2015) Jian Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Widespread intron retention diversifies most cancer transcriptomes
- (2015) Heidi Dvinge et al. Genome Medicine
- Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology
- (2015) Vânia Gonçalves et al. Biomed Research International
- Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
- (2015) Raoni Pais Siqueira et al. PLoS One
- Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
- (2014) M V Gammons et al. BRITISH JOURNAL OF CANCER
- Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
- (2014) Fran Supek et al. CELL
- Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
- (2014) V Marcel et al. CELL DEATH AND DIFFERENTIATION
- Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
- (2014) S. Das et al. MOLECULAR CANCER RESEARCH
- Akt-ing Up on SRPK1: Oncogene or Tumor Suppressor?
- (2014) Alex Toker et al. MOLECULAR CELL
- Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
- (2014) A Mavrou et al. ONCOGENE
- The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer
- (2014) Jacqueline Stockley et al. RNA Biology
- Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
- (2014) A. Shilo et al. RNA
- Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events
- (2014) Jung-Chun Lin et al. RNA
- Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation
- (2014) Avraham Maimon et al. Cell Reports
- Potential therapeutic applications of RNA cap analogs
- (2013) Marcin Ziemniak et al. Future Medicinal Chemistry
- hnRNP A1: The Swiss Army Knife of Gene Expression
- (2013) Jacques Jean-Philippe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
- (2013) D. S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Brr2p-mediated conformational rearrangements in the spliceosome during activation and substrate repositioning
- (2012) D. Hahn et al. GENES & DEVELOPMENT
- Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma
- (2012) Zheng-Jun Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- The spliceosome as a target of novel antitumour drugs
- (2012) Sophie Bonnal et al. NATURE REVIEWS DRUG DISCOVERY
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
- (2012) Olga Anczuków et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
- (2012) Kunle Odunsi et al. PLoS One
- Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
- (2012) Stephanie Gout et al. PLoS One
- Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
- (2012) Hannah L. Gautrey et al. PLoS One
- Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma
- (2011) R. Golan-Gerstl et al. CANCER RESEARCH
- Shuttling SR proteins: more than splicing factors
- (2011) Laure Twyffels et al. FEBS Journal
- SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non-Small Cell Lung Cancer Cells
- (2011) J. C. Shultz et al. MOLECULAR CANCER RESEARCH
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Functional consequences of developmentally regulated alternative splicing
- (2011) Auinash Kalsotra et al. NATURE REVIEWS GENETICS
- Evolution of SR protein and hnRNP splicing regulatory factors
- (2011) Anke Busch et al. Wiley Interdisciplinary Reviews-RNA
- Functional diversity of the hnRNPs: past, present and perspectives
- (2010) Siew Ping Han et al. BIOCHEMICAL JOURNAL
- Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
- (2010) Georgios Boukakis et al. BMC CANCER
- Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
- (2010) N. A. Olshavsky et al. CANCER RESEARCH
- Phosphorylation mechanism and structure of serine-arginine protein kinases
- (2010) Gourisankar Ghosh et al. FEBS Journal
- Expansion of the eukaryotic proteome by alternative splicing
- (2010) Timothy W. Nilsen et al. NATURE
- Alternative splicing and evolution: diversification, exon definition and function
- (2010) Hadas Keren et al. NATURE REVIEWS GENETICS
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- Serine/Arginine Protein-Specific Kinase 2 Promotes Leukemia Cell Proliferation by Phosphorylating Acinus and Regulating Cyclin A1
- (2008) S.-W. Jang et al. CANCER RESEARCH
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
- (2008) Z. Wang et al. RNA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started